Pharmaceuticals Related News

Synpromics announces a research collaboration with GE Healthcare to Extend the Toolbox for Production of Biologics

Edinburgh, UK, 4th January 2017 / Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce a research collaboration with GE Healthcare to jointly develop customised synthetic promoters optimised for GE Healthcare’s proprietary biopharmaceutical manufacturing platform. Synpromics will [...]

Amyris Enters Collaboration with Top 10 Pharmaceutical Company for Biosynthetic Drug Discovery

Amyris's Leading µPharm™ Platform Focused on Rapid Discovery of Novel Antibiotic Compound Target EMERYVILLE, Calif., Oct. 28, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, is pleased to announce it has entered into a research agreement with [...]

By | November 1st, 2016|BioPharma & Healthcare, News, Pharmaceuticals|

SynBioBeta Opens Memberships and Registration for San Francisco 2016

SynBioBeta is coming back to San Francisco this October 4th-6th at a new venue, the South San Francisco Conference Center, for the 5th Annual SynBioBeta SF 2016.  SynBioBeta SF 2016 is the prime conference for the synthetic biology industry, where [...]

Intrexon Responds to Short-Sellers’ Report

Holders of Intrexon Corporation stock are watching their portfolios carefully in wake of the anonymous publication last Thursday of a short-seller report that alleges the company’s technology is less cutting-edge than it claims and that its revenues are exaggerated. On [...]

Eli Lilly to Acquire ‘Smart Insulin’ Company Glycostasis, Inc

Eli Lilly and Company are acquiring Glycostasis, Inc., a startup aiming to create “smart insulin.” Seattle-based Glycostasis, founded by CEO Dr. John Mulligan, was incubated by Pacific Northwest Diabetes Research Institute (PNDRI), and later attracted Series A financing led by [...]

By | February 17th, 2016|BioPharma & Healthcare, News, Pharmaceuticals|

What’s Next for Synthetic Biology in Biopharmaceuticals?

In the world of biopharmaceuticals, synthetic biology has quickly started to revolutionize drug discovery and design by providing a better overall molecular understanding of disease. Throughout the industry, biologists and engineers have come together over the past several years to [...]

By | February 2nd, 2016|BioPharma & Healthcare, News, Pharmaceuticals|